C

Clearside Biomedical

CLSD

1.10000
USD
-0.02
(-1.79%)
مفتوح الان
حجم التداول
3,254
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
89,694,686
أصول ذات صلة
A
ADMP
0
(0%)
0.000000 USD
A
AUPH
-0.28000
(-4.76%)
5.60000 USD
B
BIIB
-2.500
(-1.17%)
210.710 USD
GILD
0.470
(0.62%)
76.510 USD
I
INCY
-0.680
(-1.05%)
64.390 USD
NVS
0.650
(0.58%)
112.100 USD
REGN
13.14
(1.22%)
1,091.19 USD
T
TEVA
0.100
(0.57%)
17.530 USD
V
VSTM
-0.17000
(-6.51%)
2.44000 USD
الأخبار المقالات

العنوان: Clearside Biomedical

القطاع: Healthcare
الصناعة: Biotechnology
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.